Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2012 (2012), Article ID 186320, 3 pages
http://dx.doi.org/10.1155/2012/186320
Case Report

Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome

1Clinica Medica, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche & Ospedali Riuniti, Via Tronto 10, 60126 Ancona, Italy
2U.O. di Medicina-LPA, Presidio di Loreto, 66025 Loreto, Italy
3U.O. di Radiodiagnostica, Ospedale di Casarano, 73042 Lecce, Italy
4Clinica Neurologica, Dipartimento di Medicina Sperimentale e Clinica, Polo Didattico Scientifico, Università Politecnica delle Marche & Azienda Ospedali Riuniti, Via Tronto 10, 60126 Ancona, Italy

Received 2 September 2012; Accepted 31 October 2012

Academic Editors: N. Kutukculer, Y. Nozaki, B. Sarov, and A. Vojdani

Copyright © 2012 Maria Giovanna Danieli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. Tobón, J. O. Pers, V. Devauchelle-Pensec et al., “Neurological disorders in primary Sjögren's syndrome,” Autoimmune Diseases, vol. 2012, Article ID 645967, 11 pages, 2012. View at Publisher · View at Google Scholar
  2. S. I. Mellgren, L. G. Göransson, and R. Omdal, “Primary Sjögren's syndrome associated neuropathy,” Canadian Journal of Neurological Sciences, vol. 34, no. 3, pp. 280–287, 2007. View at Google Scholar · View at Scopus
  3. A. Sghirlanzoni, D. Pareyson, and G. Lauria, “Sensory neuron diseases,” Lancet Neurology, vol. 4, no. 6, pp. 349–361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. W. Griffin, D. R. Cornblath, E. Alexander et al., “Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome,” Annals of Neurology, vol. 27, no. 3, pp. 304–315, 1990. View at Google Scholar · View at Scopus
  6. J. A. Molina, J. Benito-Leon, F. Bermejo, F. J. Jimenez-Jimenez, and J. Olivan, “Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjögren's syndrome,” Journal of Neurology Neurosurgery and Psychiatry, vol. 60, no. 6, p. 699, 1996. View at Google Scholar · View at Scopus
  7. Y. Takahashi, T. Takata, M. Hoshino, M. Sakurai, and I. Kanazawa, “Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome,” Neurology, vol. 60, no. 3, pp. 503–505, 2003. View at Google Scholar · View at Scopus
  8. S. Rist, J. Sellam, E. Hachulla et al., “Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective study,” Arthritis Care & Research, vol. 63, pp. 1339–1344, 2011. View at Google Scholar
  9. P. Willeke, B. Schlüter, H. Becker, H. Schotte, W. Domschke, and M. Gaubitz, “Mycophenolate sodium treatment in patients with primary Sjögren's syndrome: a pilot trial,” Arthritis Research and Therapy, vol. 9, no. 6, pp. 115–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Murata, K. Maeda, H. Kawai et al., “Antiganglion neuron antibodies correlate with neuropathy in Sjögren's syndrome,” NeuroReport, vol. 16, no. 7, pp. 677–681, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. F. Seite, Y. Shoenfeld, P. Youinou, and S. Hillion, “What is the contents of the magic draft IVIg?” Autoimmunity Reviews, vol. 7, no. 6, pp. 435–439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. G. Danieli, L. Pettinari, R. Moretti, F. Logullo, and A. Gabrielli, “Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application,” Autoimmunity Reviews, vol. 10, no. 3, pp. 144–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kessel, H. Ammuri, R. Peri et al., “Intravenous immunoglobulin therapy affects t regulatory cells by increasing their suppressive function,” Journal of Immunology, vol. 179, no. 8, pp. 5571–5575, 2007. View at Google Scholar · View at Scopus
  14. J. Vani, S. Elluru, V. S. Negi et al., “Role of natural antibodies in immune homeostasis: IVIg perspective,” Autoimmunity Reviews, vol. 7, no. 6, pp. 440–444, 2008. View at Publisher · View at Google Scholar · View at Scopus